Systemic Sclerosis: Clinical Trials

1 trial for Systemic Sclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow Systemic Sclerosis: new trials by email Literature Review of Systemic Sclerosis trials Research Report on Systemic Sclerosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cardiac Safe Transplants for Systemic Sclerosis
Rituximab, Fludarabine, Cyclophosphamide - Systemic Sclerosis, Scleroderma
Phase 2 / Phase 3TerminatedNorthwestern University92018-05-172020-08-12

Narrower conditions

Scleroderma, Diffuse (1)  ·  Scleroderma, Systemic (1)

Broader conditions

Connective Tissue Diseases (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Antilymphocyte Serum (1)  ·  Cyclophosphamide (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Immunoglobulins, Intravenous (1)  ·  Mesna (1)  ·  Methylprednisolone (1)  ·  Methylprednisolone Acetate (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  Octagam (1)  ·  Rituximab (1)  ·  fludarabine (1)  ·  fludarabine phosphate (1)  ·  thymoglobulin (1)

Sponsors

Northwestern University (1)

Countries

United States (1)

Top investigators

Richard Burt, MD (1)

Results publications

PMID 32612255